El interés en corto de Fluor da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Fluor. Los datos de interés en corto se actualizan cada dos semanas.

Fluor (NYSE:FLR) Bolsa, Informe de interés en corto

Fluor

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Prison

News

Politics

Legal

AXON

Trump propone reabrir Alcatraz como prisión para criminales peligrosos. ¿Cuánto costaría y qué obstáculos enfrentaría su plan?

Trump quiere reabrir Alcatraz como prisión de máxima seguridad: ¿es viable el polémico plan?

Earnings

Pre-Market Outlook

Markets

Trading Ideas

BIDU

SOHU

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: MDT, BIDU, SOHU, OXY y FLR.

5 acciones en el foco este martes: MDT, BIDU, SOHU, OXY y FLR

Short Ideas

Insider Trades

MSFT

NWSA

El Nasdaq 100 cae más de 500 puntos. Conoce las recientes ventas de insiders en Microsoft, McKesson y otras grandes empresas.

McKesson, News Corporation y otras 2 acciones que los insiders están vendiendo

Ramaco Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>, METCB))) ("Ramaco Resources" or the "Company") is pleased to announce that the Fluor Corporation ("Fluor") will deliver its full Preliminary Economic Assessment ("PEA") of Ramaco's Brook Mine on or before July 8, 2025. Today, Fluor has provided Ramaco with the summary results of that report which the Company is disclosing in a separate letter to Shareholders from Ramaco's Chairman and Chief Executive Randall Atkins.
The Fluor PEA states that the project is both commercially and technologically feasible. This report marks a significant step forward and builds on Fluor's earlier interim preliminary techno-economic analysis. The Brook Mine holds what is believed to be the nation's largest&nbsp;unconventional deposit of rare earth elements and critical minerals sourced from coal and carbonaceous ore.

METC

Fluor Confirms $1.2B Value For Ramaco's Brook Mine, Validating Feasibility Of Nation's Largest Unconventional Rare Earth Deposit

8 analysts have expressed a variety of opinions on Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $47.38, with a high estimate of $60.00 and a low estimate of $41.00. A decline of 8.44% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1750795258_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Fluor. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$60.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$48.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$49.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Sangita Jain</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$41.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Fluor. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Fluor compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Fluor's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Fluor's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FLR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Fluor analyst ratings.</a>
<h2>Unveiling the Story Behind Fluor</h2>
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
<h3>Financial Milestones: Fluor's Journey</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Fluor displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 6.64%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Fluor's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -6.05%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Fluor's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -6.39%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Fluor's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.74%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.3.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: Fluor In The Eyes Of 8 Experts

UBS analyst Steven Fisher maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and raises the price target from $48 to $60.

Price Target

UBS Maintains Buy on Fluor, Raises Price Target to $60

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer recommended buying Dover Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>).
Supporting his view, Dover, on April 24, posted better-than-expected <a href="https://www.benzinga.com/quote/DOV">earnings for the first quarter</a>.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) doesn&#8217;t make any money, Cramer said. &#8220;I just don&#8217;t know if it has the horses.&#8221;
As per the recent news, Arrowhead Pharmaceuticals, on Monday, initiated Phase 1/2a study of ARO-ALK7 for the treatment of obesity.
Cramer said Snowflake Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NASDAQ">SNOW</a>) CEO Sridhar Ramaswamy is &#8220;cerebral, and he's got a real good closing sense, and man, does he ever have momentum.&#8221;
Supporting his view, Snowflake, on May 21, reported first-quarter revenue of $1.04 billion, beating analyst estimates of $1.01 billion. The AI data cloud company reported adjusted earnings of 24 cents per share, beating analyst estimates of 21 cents per share, according to Benzinga Pro.
Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is &#8220;always a bridesmaid, never a bride,&#8221; Cramer said.
On the earnings front, Fluor, on May 2, posted mixed first-quarter 2025 results, with key metrics surpassing some expectations. Fluor&#8217;s revenue grew 6.6% year-over-year to $3.982 billion, missing the consensus of $4.18 billion. Adjusted EPS improved to 73 cents from 47 cents a year ago, above the consensus of 50 cents.
Price Action:
<ul class="wp-block-list">
<li>Arrowhead Pharmaceuticals shares gained 1.3% to settle at $16.61 on Tuesday.</li>
<li>Snowflake shares fell 0.5% to close at $209.15.</li>
<li>Dover shares gained 1.1% to close at $177.97.</li>
<li>Fluor shares gained 5.4% to settle at $43.39 on Tuesday.</li>
</ul>
Read Next<a href="Cramer: Should've Told Investors To 'Pull The Trigger' On Trade Desk, Can't Believe 'How Low' Gentex Has Fallen">: </a>
<ul class="wp-block-list">
<li><a href="Cramer: Should've Told Investors To 'Pull The Trigger' On Trade Desk, Can't Believe 'How Low' Gentex Has Fallen">Cramer: Should&#8217;ve Told Investors To &#8216;Pull The Trigger&#8217; On Trade Desk, Can&#8217;t Believe &#8216;How Low&#8217; Gentex Has Fallen</a></li>
</ul>
Image: Shutterstock

Analyst Color

Long Ideas

Media

ARWR

SNOW

Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Industrials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$220.00</td>
<td>$33.0K</td>
<td>12.0K</td>
<td>2.7K</td>
</tr>
<tr>
<td>FLR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$42.50</td>
<td>$32.7K</td>
<td>6.5K</td>
<td>2.4K</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.00</td>
<td>$33.0K</td>
<td>35.1K</td>
<td>1.6K</td>
</tr>
<tr>
<td>AMTM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$17.50</td>
<td>$39.5K</td>
<td>2.1K</td>
<td>1.1K</td>
</tr>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$80.00</td>
<td>$210.0K</td>
<td>3.2K</td>
<td>900</td>
</tr>
<tr>
<td>CSX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$32.50</td>
<td>$56.0K</td>
<td>2.5K</td>
<td>627</td>
</tr>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.00</td>
<td>$28.8K</td>
<td>1.7K</td>
<td>487</td>
</tr>
<tr>
<td>WM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$240.00</td>
<td>$96.0K</td>
<td>281</td>
<td>308</td>
</tr>
<tr>
<td>LMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$500.00</td>
<td>$98.0K</td>
<td>412</td>
<td>199</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$230.00</td>
<td>$142.8K</td>
<td>1</td>
<td>157</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we notice a call option trade that happens to be bearish, expiring in 17 day(s) on June 20, 2025. This event was a transfer of 100 contract(s) at a $220.00 strike. The total cost received by the writing party (or parties) was $33.0K, with a price of $330.0 per contract. There were 12059 open contracts at this strike prior to today, and today 2711 contract(s) were bought and sold. 
• Regarding FLR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>), we observe a call option trade with neutral sentiment. It expires in 17 day(s) on June 20, 2025. Parties traded 149 contract(s) at a $42.50 strike. The total cost received by the writing party (or parties) was $32.7K, with a price of $220.0 per contract. There were 6594 open contracts at this strike prior to today, and today 2479 contract(s) were bought and sold. 
• For EOSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>), we notice a call option sweep that happens to be bullish, expiring in 227 day(s) on January 16, 2026. This event was a transfer of 1000 contract(s) at a $10.00 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $33.0K, with a price of $33.0 per contract. There were 35195 open contracts at this strike prior to today, and today 1649 contract(s) were bought and sold. 
• Regarding AMTM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>), we observe a put option trade with bullish sentiment. It expires in 45 day(s) on July 18, 2025. Parties traded 989 contract(s) at a $17.50 strike. The total cost received by the writing party (or parties) was $39.5K, with a price of $40.0 per contract. There were 2198 open contracts at this strike prior to today, and today 1142 contract(s) were bought and sold. 
• For UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we notice a put option trade that happens to be bullish, expiring in 45 day(s) on July 18, 2025. This event was a transfer of 750 contract(s) at a $80.00 strike. The total cost received by the writing party (or parties) was $210.0K, with a price of $280.0 per contract. There were 3290 open contracts at this strike prior to today, and today 900 contract(s) were bought and sold. 
• Regarding CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), we observe a call option sweep with bullish sentiment. It expires in 227 day(s) on January 16, 2026. Parties traded 200 contract(s) at a $32.50 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $56.0K, with a price of $280.0 per contract. There were 2545 open contracts at this strike prior to today, and today 627 contract(s) were bought and sold. 
• For LUNR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>), we notice a call option sweep that happens to be bullish, expiring in 17 day(s) on June 20, 2025. This event was a transfer of 400 contract(s) at a $11.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $28.8K, with a price of $72.0 per contract. There were 1712 open contracts at this strike prior to today, and today 487 contract(s) were bought and sold. 
• Regarding WM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>), we observe a put option sweep with bullish sentiment. It expires in 17 day(s) on June 20, 2025. Parties traded 300 contract(s) at a $240.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $96.0K, with a price of $320.0 per contract. There were 281 open contracts at this strike prior to today, and today 308 contract(s) were bought and sold. 
• For LMT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), we notice a call option sweep that happens to be bullish, expiring in 73 day(s) on August 15, 2025. This event was a transfer of 70 contract(s) at a $500.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $98.0K, with a price of $1400.0 per contract. There were 412 open contracts at this strike prior to today, and today 199 contract(s) were bought and sold. 
• For AVAV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>), we notice a call option sweep that happens to be bullish, expiring in 108 day(s) on September 19, 2025. This event was a transfer of 157 contract(s) at a $230.00 strike. This particular call needed to be split into 42 different trades to become filled. The total cost received by the writing party (or parties) was $142.8K, with a price of $910.0 per contract. There were 1 open contracts at this strike prior to today, and today 157 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AMTM

AVAV

EOSE

LUNR

UBER

10 Industrials Stocks Whale Activity In Today's Session

WIIM

ATXG

BGLC

BlackSky Technology Inc. Class A Common Stock

BKSY

BYRN

CAPT

CMCO

EVEX

FTAI

IESC

INOD

KTOS

NCRA

NVVE

ONEG

RKLB

ROMA

SATL

SHIM

TPIC

ULBI

ULCC

VATE

Shares of companies within the broader industrial sector are trading higher, possibly amid overall market strength after President Trump delayed 50% EU tariffs to July.

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Friday.
Shares of Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) rose during Friday's session <a href="https://www.benzinga.com/quote/FRO/earnings">following first-quarter results</a>.
The company reported revenue of $427.9 million, surpassing the $264.2 million consensus. Adjusted EPS declined to 18 cents from 62 cents a year ago, missing the consensus of 23 cents.
Frontline shares gained 3.7% to $17.81 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Merus N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) shares jumped 30% to $54.04 as the company disclosed interim clinical data as of a February 27, 2025 data cutoff from the ongoing phase 2 trial of the bispecific antibody petosemtamab in combination with pembrolizumab.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) rose 24.7% to $34.40.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 23.4% to $114.98.</li>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) rose 23.1% to $49.03 after Wedbush raised its price target on the stock from $45 to $55 and maintained an Outperform rating.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 23.1% to $114.80.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 19.2% to $6.15.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) shares gained 16% to $29.36.</li>
<li>NexGen Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) rose 11.6% to $6.07.</li>
<li>Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) gained 8.8% to $724.54 after the company reported better-than-expected third-quarter financial results and raised guidance.</li>
<li>Cameco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) rose 8.2% to $57.13.</li>
<li>BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) gained 6.5% to $114.70.</li>
<li>Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) rose 5.4% to $39.61.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45585296/jim-cramer-says-medical-properties-trust-has-too-much-risk-likes-this-industrial-stock">Jim Cramer Says Medical Properties Trust Has &#8216;Too Much Risk,&#8217; Likes This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

BWXT

INTU

MRUS

Nuveen Arizona Dividend Advantage Municipal Funds 3

OKLO

Frontline, Merus, Intuit And Other Big Stocks Moving Higher On Friday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fluor.com%2F&amp;esheet=54256315&amp;newsitemid=20250519864245&amp;lan=en-US&amp;anchor=Fluor+Corporation&amp;index=1&amp;md5=e7e9a1d9adb37b80a5108bff2f79f317">Fluor Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE).
&nbsp;
Bayer's Cell Therapy Launch Facility in Berkeley, California.
LEED v4 Platinum certification is the highest level of recognition for sustainable building practices and indicates that a building meets the highest standards for sustainability.
Fluor's scope of work included the engineering, procurement, construction management, commissioning, qualification and validation for the 144,000-square-foot, state-of-the-art facility. It features 30,000 square feet of cleanroom space dedicated to advancing cell therapy production for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
"Fluor and Bayer collaborated to deliver Bayer's first fully electric pharmaceutical manufacturing plant, and we met an aggressive schedule to support client and patient needs," said Richard Meserole, President of Fluor's Advanced Technologies &amp; Life Sciences business. "Fluor secured LEED v4 Platinum Certification and ISPE Facility of the Year designation through effective collaboration with our trade partners, lean construction methods, and dedication to quality."
Sustainability benefits for the facility include 52.6% energy cost savings via LED, high-efficiency lighting, heat pump and rooftop solar installation. The facility boasts 100% process water reduction, 98% onsite management of rainfall high efficiency plumbing fixtures, 65% recycled content installation, high use of sustainable materials, land use maximization and various innovation credits.
This is the second new facility built by Fluor on Bayer's Biotech campus in Berkeley. Previously, Fluor completed construction of Bayer's state-of-the-art Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center in 2021.

Fluor-Built Bayer Facility Becomes First in Western US to Earn LEED v4 Platinum for Sustainability

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said no to O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>). 
&#8220;You want to buy the one that's not going to stock split, which is AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>),&#8221;<a href="https://www.benzinga.com/quote/ORLY/earnings"> he added.</a>
Adding support to his view, O&#8217;Reilly Automotive posted first-quarter earnings of $9.35 per share on April 23, missing market estimates of $9.94 per share. The company's quarterly sales came in at $4.14 billion versus expectations of $4.17 billion.
AutoZone has outperformed the market over the past 15 years by 10.81% on an annualized basis producing an average annual return of 22.06%. Currently, the company has a market capitalization of $62.8 billion.
See Also: <a href="https://www.benzinga.com/insights/news/25/05/45322871/heres-how-much-100-invested-in-autozone-15-years-ago-would-be-worth-today">Here&#8217;s How Much $100 Invested In AutoZone 15 Years Ago Would Be Worth Today</a>
Cramer said the last couple quarters have been weak for ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>). He recommended buying Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) over ASML.
Supporting his view, ASML Holding reported a first-quarter sales miss on April 16. Sequentially, revenue declined by 16.75% from €9.3 billion in the fourth quarter.
Cramer said no to Onto Innovation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>), adding that he likes Agilent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>).
Onto Innovation issued second-quarter guidance below estimates on May 8. The company sees second-quarter adjusted EPS of $1.21-$1.35, versus market estimates of $1.50. The company expects sales of $240.00 million —$260.00 million, versus projections of $269.10 million.
The Mad Money host said no to Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>). &#8220;Engineering and construction, we're going to buy letter J, we'll buy Jacobs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>),&#8221; he added.
UBS analyst Steven Fisher maintained Fluor with a buy rating on May 7 and lowered the price target from $49 to $48.
Price Action:
<ul class="wp-block-list">
<li>ASML shares fell 1.4% to settle at $758.36 on Thursday.</li>
<li>O'Reilly Automotive shares rose 3.4% to close at $1,370.13 during the session.</li>
<li>Onto Innovation shares fell 5.8% to settle at $98.04.</li>
<li>Fluor shares fell 0.5% to close at $38.53 on Thursday.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

ASML

LRCX

ONTO

ORLY

Jim Cramer Prefers AutoZone Over Rival: 'Buy The One That's Not Going To Stock Split'

<a href="https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html" title="https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html">https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html</a>

Macro Economic Events

Economics

'Draft Executive Orders Aim To Speed Construction Of Nuclear Plants; The Potential Actions Could Include Overhauling The Nuclear Regulatory Commission And Leaning On The U.S. Military To Deploy New Reactors' - NY Times

UBS analyst Steven Fisher maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and lowers the price target from $49 to $48.

UBS Maintains Buy on Fluor, Lowers Price Target to $48

President Donald Trump on Sunday announced his intention to reconstruct and reopen Alcatraz, the infamous former prison on an island in San Francisco Bay, as a functioning maximum-security facility for &#8220;America's most ruthless<a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline"> and violent offenders.&#8221;&nbsp;</a>
What To Know: Trump described the move as a symbol of &#8220;Law, Order, and Justice&#8221; in a post on Truth Social and suggested the prison would be significantly expanded and modernized to accommodate the most dangerous criminals.
Read Next: <a href="https://www.benzinga.com/news/management/25/05/45180224/these-ev-makers-could-shine-if-musk-leaves-tesla?utm_source=articleShare">These EV Makers Could Shine If Musk Leaves Tesla&nbsp;</a>
Alcatraz operated as a federal penitentiary from 1934 to 1963 and housed notorious criminals like Al Capone and George &#8220;Machine Gun&#8221; Kelly. The prison was closed due to high operational costs, deteriorating infrastructure and logistical challenges. 
Everything, including food, fuel and water, had to be shipped by boat, making it nearly three times more expensive to run than other federal prisons. 
John Martini, an expert on Alcatraz history who served as a park ranger on the island, <a href="https://www.sfchronicle.com/sf/article/alcatraz-trump-prison-reopen-reaction-20309745.php">told</a> the San Francisco Chronicle that it would be impossible to reopen the prison because the building is "totally inoperable," with no water or sewage, and electricity only in certain parts.
"If the discussion is to rebuild the prison building to hold people, I don't think that would be feasible," Martini said. "It would have to be torn down and rebuilt."
What's Next: Reopening Alcatraz as a federal prison would require a major federal investment, with upfront costs likely in the hundreds of millions and ongoing annual expenses far exceeding those of typical mainland prison.&nbsp;
Large-scale construction and infrastructure consultants like AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) and Fluor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) that specialize in government infrastructure and complex restoration projects would likely be essential for rebuilding Alcatraz.&nbsp;
Private prison firms including Geo Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) and CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWX#NYSE">CWX</a>) could also be called upon to operate the location once restoration is complete.&nbsp;
A rebuilt Alcatraz prison would also need security, communications and surveillance solutions from providers who specialize in public safety and correctional facilities like Axon Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) and Motorola Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>).&nbsp;&nbsp;
Details of the plan to reopen Alcatraz remain unclear, including proposed costs or a timeline for expanding and opening the facility. However, the Bureau of Prisons, Justice Department, FBI and Homeland Security are expected to work on the project.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45194998/saudi-arabias-oil-power-play-jolts-markets-can-diamondback-and-rivals-survive-the-squeeze?utm_source=articleShare">Saudi Arabia&#8217;s Oil Power Play Jolts Markets: Can Diamondback And Rivals Survive The Squeeze?</a></li>
</ul>
Image: Shutterstock

President Trump Wants To Reopen Alcatraz: Here's What It Would Take

Truist Securities analyst Jamie Cook maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and raises the price target from $45 to $47.

Truist Securities Maintains Buy on Fluor, Raises Price Target to $47

Fluor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) shares are trading slightly higher after the company posted mixed <a href="https://www.benzinga.com/pressreleases/25/05/b45160690/fluor-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">first-quarter 2025 results</a>, with key metrics surpassing some expectations.
Fluor's revenue grew 6.6% year-over-year to $3.982 billion, missing the consensus of $4.18 billion. Adjusted EPS improved to 73 cents from 47 cents a year ago, above the consensus of 50 cents.
Sales by segment: Urban Solutions $2.16 billion (+45.8% YoY), Energy Solutions $1.21 billion (-15.8% YoY), Mission Solutions $597 million (-0.67% YoY), and Others $22 million (-90% YoY).
Fluor recorded a total segment profit of $131 million, compared to $118 million a year ago. The margin expanded 13 bps to 3.3%.
The company reported a net loss from core operations of $251 million, down from earnings of $67 million a year ago.
Fluor reported $5.8 billion in new awards, down 17% year over year, with 87% reimbursable. Backlog fell 12.3% to $28.7 billion, and legacy project backlog dropped 53% to $585 million.
Adjusted EBITDA rose 76.1% year-over-year to $155 million; the margin gained 154 bps to 3.9%.
At the end of the quarter, Fluor's cash and marketable securities at the end of the year were $2.5 billion. Operating cash flow of ($286) million, down from ($111) million year over year, due to higher working capital on major projects.
Fluor accelerated first-quarter share repurchases to $142 million and is targeting $600 million in total buybacks for 2025.
Fluor is engaging with clients to address potential economic uncertainty while maintaining its 2025 guidance, which excludes specific adjustment items.
2025 Outlook reaffirmed: Flour's adjusted EBITDA is projected at $575 million to $675 million, with adjusted EPS between $2.25 and $2.75 per share versus the $2.48 consensus, assuming a 30%-35% tax rate.
FLR Price Action: Fluor shares are trading higher by 0.28% at $35.84 at publication on Friday.
Photo: Shutterstock

Guidance

Fluor Q1 Beats EPS Estimates, Reaffirms Strong 2025 Outlook

FLR stock has given up its prior gain. Flour shares were trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued FY25 adjusted EPS guidance with its midpoint above estimates.

Flour shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued FY25 adjusted EPS guidance with its midpoint above estimates.

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) affirms FY2025 Adj EPS guidance from $2.25-$2.75 to $2.25-$2.75 vs $2.48 analyst estimate..

Fluor Affirms FY2025 Adj EPS Guidance of $2.25-$2.75 vs $2.48 Est

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.50 by 46 percent. This is a 55.32 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $3.98 billion which missed the analyst consensus estimate of $4.18 billion by 4.67 percent. This is a 6.64 percent increase over sales of $3.73 billion the same period last year.

Earnings Beats

Earnings Misses

Fluor Q1 Adj. EPS $0.73 Beats $0.50 Estimate, Sales $3.98B Miss $4.18B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $1.98 billion. 
• Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $79.89 million. 
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $1.43 billion. 
• Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) is expected to report quarterly loss at $0.83 per share on revenue of $1.08 billion. 
• Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $427.39 million. 
• United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $925.42 million. 
• Telephone and Data Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.19 billion. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is likely to report quarterly loss at $0.03 per share on revenue of $415.45 million. 
• Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.25 billion. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $108.98 million. 
• Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $260.12 million. 
• Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $526.63 million. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.70 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.25 per share on revenue of $2.16 billion. 
• SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $351.00 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is projected to report quarterly loss at $0.18 per share on revenue of $71.26 million. 
• Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $205.52 million. 
• Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is likely to report quarterly earnings at $0.50 per share on revenue of $4.18 billion. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its first quarter. 
• Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $421.40 million. 
• nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $790.29 million. 
• Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is projected to report quarterly loss at $0.25 per share on revenue of $522.45 million. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $295.59 million. 
• Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $273.46 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $39.25 million. 
• City Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIO#NYSE">CIO</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $42.20 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $168.05 million. 
• AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $3.10 billion. 
• Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $85.63 million. 
• Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $559.99 million. 
• T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) is projected to report quarterly earnings at $2.13 per share on revenue of $1.78 billion. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is estimated to report quarterly earnings at $2.71 per share on revenue of $6.25 billion. 
• Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $4.64 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $2.95 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is likely to report quarterly earnings at $2.18 per share on revenue of $48.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $9.68 billion. 
• ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) is estimated to report earnings for its first quarter. 
• Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is expected to report quarterly earnings at $1.65 per share on revenue of $79.13 billion. 
• IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) is projected to report earnings for its second quarter. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $9.73 billion. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $367.73 million. 
• Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $123.71 million. 
• Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) is estimated to report quarterly earnings at $6.35 per share on revenue of $60.39 billion. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.74 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $715.49 million. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $3.04 billion. 
• inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is likely to report quarterly loss at $0.10 per share on revenue of $28.07 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is projected to report quarterly loss at $0.07 per share on revenue of $21.16 million. 
• Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $297.11 million. 
• Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) is projected to report quarterly loss at $0.09 per share on revenue of $72.98 million. 
• NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) is expected to report earnings for its first quarter. 
• AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $347.25 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $86.09 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

AMRX

ASIX

ATMU

BBUC

BEPC

BFLY

BTSG

CBOE

CRTO

FLGT

FUBO

INTT

JOUT

LBTYA

MSGS

PIPR

PRLB

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SHEL

TILE

TROW

VNCE

WLKP

Earnings Scheduled For May 2, 2025

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is preparing to release its quarterly earnings on Friday, 2025-05-02. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Fluor to report an earnings per share (EPS) of $0.67.
The market awaits Fluor's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.29, leading to a 0.55% drop in the share price the following trading session.
Here's a look at Fluor's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.76</td>
<td>0.68</td>
<td>0.54</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.48</td>
<td>0.51</td>
<td>0.85</td>
<td>0.47</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-14.000000000000002%</td>
<td>0.0%</td>
<td>-6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746108133_0.png" alt="eps graph" />
<h3>Fluor Share Price Analysis</h3>
Shares of Fluor were trading at $34.89 as of April 30. Over the last 52-week period, shares are down 7.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Opinions on Fluor</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Fluor.
The consensus rating for Fluor is Buy, derived from 9 analyst ratings. An average one-year price target of $47.22 implies a potential 35.34% upside.
<h3>Comparing Ratings with Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Valmont Industries, Dycom Industries and WillScot Holdings, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Valmont Industries, with an average 1-year price target of $373.25, suggesting a potential 969.79% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Dycom Industries, with an average 1-year price target of $199.83, suggesting a potential 472.74% upside.</li>
<li>Analysts currently favor an Neutral trajectory for WillScot Holdings, with an average 1-year price target of $35.5, suggesting a potential 1.75% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Valmont Industries, Dycom Industries and WillScot Holdings, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fluor</td>
<td>Buy</td>
<td>11.52%</td>
<td>$208M</td>
<td>60.10%</td>
</tr>
<tr>
<td>Valmont Industries</td>
<td>Buy</td>
<td>-6.55%</td>
<td>$313.02M</td>
<td>5.49%</td>
</tr>
<tr>
<td>Dycom Industries</td>
<td>Outperform</td>
<td>13.87%</td>
<td>$196.58M</td>
<td>2.64%</td>
</tr>
<tr>
<td>WillScot Holdings</td>
<td>Neutral</td>
<td>-1.61%</td>
<td>$336.35M</td>
<td>8.61%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Fluor ranks highest in Gross Profit and Return on Equity among its peers. It ranks second in Revenue Growth.
<h3>Get to Know Fluor Better</h3>
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
<h3>Understanding the Numbers: Fluor's Finances</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Fluor's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.52% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Fluor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 43.73%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Fluor's ROE excels beyond industry benchmarks, reaching 60.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Fluor's ROA stands out, surpassing industry averages. With an impressive ROA of 22.94%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Fluor's debt-to-equity ratio is below the industry average at 0.28, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/FLR/earnings">To track all earnings releases for Fluor visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Fluor's Earnings Preview

Press Releases

Fluor Names Tracey Cook Chief Human Resources Officer

Fluor Selected for State Highway 6 Project in College Station, Texas

Fluor to Provide EPCM Services for a Second Multi-Billion-Dollar Pharmaceutical Facility in Indiana

Fluor Corporation to Hold First Quarter Earnings Conference Call

HPE Appoints Stacy Dillow as Chief People Officer

Fluor to Participate in Upcoming Investor Conferences

Fluor Reports First Quarter 2025 Results

Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification

Comments

Fluor

Interés en corto

Fluor (NYSE:FLR) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL